PMPRB Announces Scoping Paper for the Consultation on New Guidelines and Opens Stakeholder Registration for Policy Roundtables


On November 10, 2023, the Patented Medicine Prices Review Board (PMPRB) released its Scoping Paper for the Consultation on the Board’s Guidelines (Scoping Paper) and opened registration for stakeholders to participate in Policy Roundtable Discussions on December 5, 2023 (in English) and December 6, 2023 (in French).

As previously reported, the PMPRB recently adopted its Amended Interim Guidance to evaluate the pricing of patented medicines. Additionally, we reported that the PMPRB announced the launch of the first phase of consultations for preparing new guidelines and informed stakeholders of the upcoming Policy Roundtable Discussions.

The Scoping Paper aims to facilitate the consultation process and lead to more informed, focused, and productive feedback for the PMPRB in developing its new guidelines. The Scoping Paper is to be used for discussion purposes to advance consultation rather than a “definitive articulation of the PMPRB’s position on these issues.” The discussion themes in the Scoping Paper include:

More Information

For more information, please contact the authors of this article or any member of our Intellectual Property Group.